Retinoic acid (RA) in association with chemotherapy or with arsenic trioxide (ATO) results in high cure rates of acute promyelocytic leukemia (APL). We show that RA-induced differentiation of human leukemic cell lines and primary blasts dramatically increases their sensitivity to endoplasmic reticulum (ER) stress-inducing drugs at doses that are not toxic in the absence of RA. In addition, we demonstrate that the PERK pathway, triggered in response to ER stress, has a major protective role. Moreover, low amounts of pharmacologically induced ER stress are sufficient to strongly increase ATO toxicity. Indeed, in the presence of ER stress, ATO efficiently induced apoptosis in RA-sensitive and RA-resistant APL cell lines, at doses ineffective in the absence of ER stress. Our findings identify the ER stress-related pathways as potential targets in the search for novel therapeutic strategies in AML.

Masciarelli, S., Capuano, E., Ottone, T., Divona, M., De Panfilis, S., Banella, C., et al. (2018). Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress. LEUKEMIA, 32(2), 285-294 [10.1038/leu.2017.231].

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress

Ottone T.;Noguera N. I.;Picardi A.;Lo-Coco F.;
2018-01-01

Abstract

Retinoic acid (RA) in association with chemotherapy or with arsenic trioxide (ATO) results in high cure rates of acute promyelocytic leukemia (APL). We show that RA-induced differentiation of human leukemic cell lines and primary blasts dramatically increases their sensitivity to endoplasmic reticulum (ER) stress-inducing drugs at doses that are not toxic in the absence of RA. In addition, we demonstrate that the PERK pathway, triggered in response to ER stress, has a major protective role. Moreover, low amounts of pharmacologically induced ER stress are sufficient to strongly increase ATO toxicity. Indeed, in the presence of ER stress, ATO efficiently induced apoptosis in RA-sensitive and RA-resistant APL cell lines, at doses ineffective in the absence of ER stress. Our findings identify the ER stress-related pathways as potential targets in the search for novel therapeutic strategies in AML.
2018
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/15 - MALATTIE DEL SANGUE
English
Masciarelli, S., Capuano, E., Ottone, T., Divona, M., De Panfilis, S., Banella, C., et al. (2018). Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress. LEUKEMIA, 32(2), 285-294 [10.1038/leu.2017.231].
Masciarelli, S; Capuano, E; Ottone, T; Divona, M; De Panfilis, S; Banella, C; Noguera, Ni; Picardi, A; Fontemaggi, G; Blandino, G; Lo-Coco, F; Fazi, F
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Masciarelli_2018.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.56 MB
Formato Adobe PDF
1.56 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/195500
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 31
social impact